This week, Stryker will commence commercial launch of the Serrato™ pedicle screw and the Tritanium® C Anterior Cervical Cage.
Serrato pedicle screws, which received FDA 510(k) clearance in mid-2Q17, were implanted by >100 U.S. surgeons during initial launch—ahead of full commercialization. The dual-thread screws with serrated flutes are designed to lower the amount of insertion torque required, and “True-Tip” geometry is intended to support precise insertion. These features are intended to increase speed and enhance surgical efficiency.
The Tritanium C Anterior Cervical Cage was FDA-cleared in late 3Q17, and adds to the company’s line of highly-porous devices enabled by the AMagine™ additive manufacturing approach.
This week, Stryker will commence commercial launch of the Serrato™ pedicle screw and the Tritanium® C Anterior Cervical Cage.
Serrato pedicle screws, which received FDA 510(k) clearance in mid-2Q17, were implanted by >100 U.S. surgeons during initial launch—ahead of full commercialization. The dual-thread screws with serrated flutes are...
This week, Stryker will commence commercial launch of the Serrato™ pedicle screw and the Tritanium® C Anterior Cervical Cage.
Serrato pedicle screws, which received FDA 510(k) clearance in mid-2Q17, were implanted by >100 U.S. surgeons during initial launch—ahead of full commercialization. The dual-thread screws with serrated flutes are designed to lower the amount of insertion torque required, and “True-Tip” geometry is intended to support precise insertion. These features are intended to increase speed and enhance surgical efficiency.
The Tritanium C Anterior Cervical Cage was FDA-cleared in late 3Q17, and adds to the company’s line of highly-porous devices enabled by the AMagine™ additive manufacturing approach.
Copy to clipboard 
